Dr. Lal PathLabs Ltd

Dr. Lal PathLabs Ltd

LALPATHLAB

 3,298.16
 55.83
1.72%
Healthcare
 0.00
(%)1D
Updated: 12 Sep 2025, 03:31:24 pm IST
Stock Score
Open Price
 3,233.22
Prev. Close
 3,242.33
 3,218.06
Day Low
 3,304.40
Day High

 2,268.44
52 Week Low
 3,594.64
52 Week High

Quick Bite

Price To Earnings Ratio

56.59

Sector PE

68.76

PB Ratio

13.03

Sector PB

6.10

EPS

58.28

Dividend Yield

0.97

Today's Volume

75.849 K

5 Day Avg. Volume

75.902 K

PEG Ratio

1.57

Market Cap.

₹ 27,120.00 Cr.

News & Events

About Dr. Lal PathLabs Ltd

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.

Dr. Lal PathLabs Ltd Share Price

Dr. Lal PathLabs Limited is an Indian company providing diagnostic and related healthcare tests and services. The company's activities include management of biochemistry, haematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology and other pathological and radiological research laboratories. It offers a variety of condition-based tests, including allergies, diabetes, health checks, viral infections, fever, heart disease, hypertension, cancer, miscarriages, anaemia, arthritis, breast cancer, diphtheria, liver disease, bone disease, abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscle disorders and viral infections. The company's subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited and Dr. Lal PathLabs Nepal Private Limited.

Dr. Lal PathLabs Ltd FAQs

How to Buy Dr. Lal PathLabs Ltd Share?

up
To purchase Dr. Lal PathLabs Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Dr. Lal PathLabs Ltd (ticker symbol: LALPATHLAB) on the trading platform provided by your broker and purchase the shares.

What's Dr. Lal PathLabs Ltd share price today?

up
The stock price of Dr. Lal PathLabs Ltd as of 14 Sep 2025 is ₹3,298.16

What is the Market Cap of Dr. Lal PathLabs Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 14 Sep 2025, Dr. Lal PathLabs Ltd (ticker symbol: LALPATHLAB) has a market capitalisation of approximately ₹2,71,20,00,00,000.00

What is the PE and PB ratio of Dr. Lal PathLabs Ltd?

up
Dr. Lal PathLabs Ltd Ltd's price-to-book ratio as of 14 Sep 2025 is 13.03, reflecting the market's valuation compared to its asset value. As of 14 Sep 2025, the trailing twelve months P/E (price-to-earnings) ratio is 56.59, indicating the market values the company at around ₹56.59 for every ₹1 of earnings

What is the 52 Week High and Low of Dr. Lal PathLabs Ltd Share?

up
Dr. Lal PathLabs Ltd Ltd (LALPATHLAB) hit its 52-week high at ₹3,594.64, and its 52-week low at ₹2,268.44.
Begin your investment journey today
Login/Register
Start Now